Immunotherapy kinder than chemotherapy for patients with head and neck cancer

(Institute of Cancer Research) The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer -- easing many of the negative effects of the disease on patients' quality of life.